HomeStock ScreenerJHS Svendgaard Laboratories

JHS Svendgaard Laboratories Share Price | JHS Svendgaard Laboratories Stock Screener

JHS Personal Care
Share Price NSE
₹7.39
▼ -0.01 (-0.14%)
2026-07-17 00:00:00
Share Price BSE
₹7.53
▲ 0.15 (2.03%)
2026-07-17 00:00:00
As of July 17, 2026, the JHS Svendgaard Laboratories share price (NSE: JHS) is ₹7.39 on NSE and ₹7.53 on BSE, down 0.14% from the previous close, with shares trading between ₹7.30 and ₹7.54, and a 52-week range of ₹6.55–₹13.56. Analyse JHS price trends and track historical price performance. Use the JHS Svendgaard Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
JHS Svendgaard Laboratories Market Cap ₹65.82 Cr.
JHS P/E Ratio (TTM) -34.36
JHS Svendgaard Laboratories P/B Ratio 0.38
EPS (TTM) ₹-0.22
Dividend Yield -
Debt to Equity 0.03
JHS 52 Week High ₹13.56
JHS Svendgaard Laboratories 52 Week Low ₹6.55
Operating Margin -5.00%
Profit Margin -12.12%
JHS Revenue (TTM) ₹33.00
EBITDA ₹-1.00
Net Income ₹-4.00
Total Assets ₹215.00
Total Equity ₹175.00

JHS Svendgaard Laboratories Share Price Chart

Screen JHS Svendgaard Laboratories share price with an interactive chart. Analyse JHS price trends and volatility across different timeframes.

JHS Svendgaard Laboratories Company Profile - Fundamental Screener

Screen JHS Svendgaard Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for JHS shares.
Sector Consumer Goods
Industry Personal Care
Sub-Sector Personal Care
Segment E
ISIN INE544H01014

JHS Svendgaard Laboratories Balance Sheet Screener

Screen JHS balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
Assets
Total Assets 215 201 197 228 222 228 241 221 208 155
Current Assets 63 54 44 85 79 121 130 102 103 43
Fixed Assets 93 90 90 65 59 63 66 71 71 65
Liabilities
Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 8 4 4 18 8 7 8 2 2 1
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 175 173 170 174 195 198 185 181 174 134
Share Capital 87 86 78 78 65 64 61 61 61 44
Reserves & Surplus 87 85 92 95 121 124 117 116 113 86

JHS Svendgaard Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen JHS Svendgaard Laboratories income statement and profit fundamentals. Analyze JHS quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for JHS Svendgaard Laboratories share price evaluation.
Item 2026-Mar 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept 2024-Jun 2024-Mar 2023-Dec 2023-Sept 2023-Jun 2023-Mar 2022-Dec 2022-Sept
Revenue 33 24 23 25 27 23 21 25 23 17 19 16 29 23 24
Expenses 34 22 21 22 33 22 21 23 21 14 19 18 44 24 23
EBITDA -1 2 2 3 -7 1 0 2 2 2 1 -2 -15 -1 1
Operating Profit % -5.00% 7.00% 4.00% 7.00% -33.00% 1.00% -4.00% 8.00% 4.00% 0.00% 2.00% -13.00% -102.00% -10.00% -9.00%
Depreciation 2 2 2 2 2 2 2 2 2 2 2 1 2 2 2
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Profit Before Tax -3 0 0 1 -9 -2 -2 0 0 1 -1 -3 -17 -3 -1
Tax 1 -1 0 0 -2 0 8 1 1 1 0 -1 -6 0 0
Net Profit -4 1 0 1 -7 -2 -10 -1 -1 0 -1 -3 -11 -3 -1
EPS -0.42 0.09 -0.02 0.12 -0.84 -0.21 -1.24 -0.08 -0.10 0.00 -0.09 -0.33 -1.37 -0.24 -0.11

JHS Svendgaard Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen JHS cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March
Operating Activities -5 -9 23 -9 12 10 -11 14 -4 -4
Investing Activities -20 -21 10 -5 -2 -11 -7 -27 -3 2
Financing Activities 23 2 -1 -2 10 1 13 14 10 4
Net Cash Flow -2 -28 32 -16 20 0 -5 0 3 2

JHS Svendgaard Laboratories Shareholding Pattern Screener

See JHS Svendgaard Laboratories shareholding pattern with promoter, FII, and DII holdings. Check JHS Svendgaard Laboratories promoter holding and ownership changes for JHS on TickJournal.
Item 2026-Mar 2026-Feb 2025-Dec 2025-Sept 2025-Jun 2025-Mar 2024-Dec 2024-Sept
Promoter Holding 33.85% 33.85% 34.56% 34.56% 34.56% 34.56% 34.56% 34.56%
FII Holding 3.60% 3.60% 1.57% 1.57% 1.59% 1.60% 1.59% 1.69%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 46.61% 46.63% 47.59% 47.30% 47.00% 46.91% 47.05% 46.53%
Other Holding 15.94% 15.93% 16.29% 16.57% 16.85% 16.93% 16.80% 17.22%
Shareholder Count 25,330 25,377 25,151 25,007 25,155 25,567 26,276 25,994

JHS Svendgaard Laboratories Share Dividend Screener - Share Yield Analysis

Check JHS Svendgaard Laboratories dividend history with payout and yield data. View JHS Svendgaard Laboratories dividend details including ex-dates and amounts for JHS stock.
No dividends declared by JHS Svendgaard Laboratories.

JHS Svendgaard Laboratories Stock Index Membership

See which indices include JHS Svendgaard Laboratories stock. Check JHS index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
JHS Svendgaard Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

JHS Svendgaard Laboratories Market Events Screener - Corporate Actions

Get JHS Svendgaard Laboratories corporate actions including splits, bonuses, and buybacks. Check JHS Svendgaard Laboratories stock events that may affect JHS share price.
Announcement Date Record Date Event Type Information Price Impact
2026-05-26 2026-05-26 Quarterly Result Announcement NA 0.70%
2026-02-10 2026-02-10 Quarterly Result Announcement NA -1.42%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -7.53%
2025-09-20 2025-09-20 Annual General Meeting NA 6.07%
2025-08-12 2025-08-12 Quarterly Result Announcement NA 2.70%
2025-05-27 2025-05-27 Quarterly Result Announcement NA -0.50%
2025-02-11 2025-02-11 Quarterly Result Announcement NA -6.08%
2024-11-13 2024-11-13 Quarterly Result Announcement NA -7.49%
2024-09-10 2024-09-10 Annual General Meeting NA 37.29%
2024-07-04 2024-07-04 Extraordinary General Meeting NA 7.82%

JHS Svendgaard Laboratories Competitors Screener - Peer Comparison

Screen JHS competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Godrej Consumer Products 109,354 59.85 15,100 2.86% 1,985 55.14
Dabur India 77,859 42.11 13,792 5.18% 1,869 51.12
Colgate Palmolive 55,077 42.11 6,124 -0.89% 1,325 47.29
P&G Hygiene and Health Care 28,910 33.88 4,282 25.49% 863 41.74
Cupid 27,812 265.00 358 76.04% 110 66.46
Gillette 25,679 39.07 3,100 36.98% 648 55.94
Emami 18,649 23.72 3,780 -2.52% 757 61.26
Mamaearth 15,396 76.77 2,392 11.48% 197 74.26
Bajaj Consumer Care 8,627 45.90 1,153 15.30% 190 68.60
Anondita Medicare 1,970 61.21 137 78.24% 36 41.53

JHS Svendgaard Laboratories Company Announcements - News Screener

Screen JHS latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-06-30 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-06-29 Shareholder Meeting / Postal Ballot-Notice of Postal Ballot -
2026-06-25 Announcement under Regulation 30 (LODR)-Meeting Updates -
2026-06-24 Closure of Trading Window -
2026-05-28 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-05-26 Statement Of Deviation For Quarter Ended 31 March 2026 -
2026-05-26 Audited Financial Results For Quarter And Year Ended 31 March 2026. -
2026-05-26 Board Meeting Outcome for Outcome For Board Meeting Dated 26 May 2025. -
2026-05-26 Compliances-Reg.24(A)-Annual Secretarial Compliance -
2026-05-20 Board Meeting Intimation for Audited Financial Results For The Quarter And Half Year Ended 31 March 2026 -
2026-04-30 Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A -
2026-04-27 Announcement under Regulation 30 (LODR)-Change in RTA -
2026-04-15 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-04-15 Announcement under Regulation 30 (LODR)-Change in RTA -
2026-04-13 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-04-01 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-03-19 Closure of Trading Window -
2026-02-12 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-02-10 Statement Of Deviation Or Variation Under Regulation 32 Of SEBI (LODR) Regulation 2015 For The Quarter Ended December 31 2025 -